Food and Drug Administration Amendments Act of 2007

E167140

The Food and Drug Administration Amendments Act of 2007 is a U.S. law that expanded the FDA’s authority over drug and device safety, clinical trials, and post-market surveillance, while enhancing transparency and user fee programs.

Try in SPARQL Jump to: Surface forms Statements Referenced by

All labels observed (4)

Statements (48)

Predicate Object
instanceOf United States federal statute
health law
abbreviation FDAAA
aimsTo enhance FDA resources through user fees
improve device safety monitoring
improve drug safety monitoring
increase transparency of clinical research
strengthen post-market surveillance
amends Federal Food, Drug, and Cosmetic Act
containsProvision active risk communication to healthcare professionals
drug labeling safety updates
pediatric research incentives
post-market risk identification and analysis system
country United States of America
surface form: United States
creates FDA Risk Evaluation and Mitigation Strategies authority
FDA authority to mandate clinical trial registration
FDA authority to mandate clinical trial results reporting
FDA authority to require post-marketing clinical trials
FDA authority to require post-marketing studies
FDA authority to require safety-related labeling changes
FDA authority to restrict distribution of certain drugs
effectiveIn United States of America
surface form: United States
enactedBy 110th United States Congress
establishes ClinicalTrials.gov results reporting requirements
establishesProgram Food and Drug Administration Safety and Innovation Act of 2012
surface form: Medical Device User Fee and Modernization Act reauthorization

Prescription Drug User Fee Act of 1992
surface form: Prescription Drug User Fee Act reauthorization

pediatric drug user fee program
expandsAuthorityOf Food and Drug Administration
surface form: U.S. Food and Drug Administration
hasSection Food and Drug Administration Amendments Act of 2007 self-linksurface differs
surface form: Title II—Medical Device User Fee Amendments of 2007

Food and Drug Administration Amendments Act of 2007 self-linksurface differs
surface form: Title I—Prescription Drug User Fee Amendments of 2007

Title VIII—Clinical Trial Databases
legalDomain food and drug law
public health law
primaryAgencyAffected Food and Drug Administration
surface form: U.S. Food and Drug Administration
publicLawNumber Public Law 110-85
regulates biological products
clinical trials of drugs and devices
medical devices
prescription drugs
shortName Food and Drug Administration Amendments Act of 2007 self-linksurface differs
surface form: FDA Amendments Act of 2007
signedBy George W. Bush
signingDate 2007-09-27
subjectOf clinical trial transparency
device safety
drug safety
post-market surveillance
title An Act to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish a user-fee program for pediatric drugs, and for other purposes
yearEnacted 2007

Referenced by (5)

Full triples — surface form annotated when it differs from this entity's canonical label.

Federal Food, Drug, and Cosmetic Act amendedBy Food and Drug Administration Amendments Act of 2007
FDC Act amendedBy Food and Drug Administration Amendments Act of 2007
Food and Drug Administration Amendments Act of 2007 shortName Food and Drug Administration Amendments Act of 2007 self-linksurface differs
this entity surface form: FDA Amendments Act of 2007
Food and Drug Administration Amendments Act of 2007 hasSection Food and Drug Administration Amendments Act of 2007 self-linksurface differs
this entity surface form: Title I—Prescription Drug User Fee Amendments of 2007
Food and Drug Administration Amendments Act of 2007 hasSection Food and Drug Administration Amendments Act of 2007 self-linksurface differs
this entity surface form: Title II—Medical Device User Fee Amendments of 2007